平台入口

姜继宗

创建时间:  2020-06-24  孙湛蓉   浏览次数:   返回


个人介绍

姜继宗2017年毕业于上海中医药大学,获得博士学位;2017.07-2019.09,中国科学院上海药物研究所,博士后;20199月入职上海大学医学院任讲师。主要从事分子药剂学研究。主持和参与国家自然科学基金青年科学基金,教育部博士点基金。已发表科研论文10余篇,其中SCI收录6篇。 代表性论文发表在《Drug Development and Industrial Pharmacy》、《Applied Materials Today》、《Toxicology in Vitro》等杂志。


主要研究方向

1. 基于纳米技术修复受损心脏的研究

2. 纳米靶向制剂

3. 仿生纳米递药系统


代表性学术成果

论文

1. Jiang JZ*. Cell-penetrating peptide-mediated nanovaccine delivery. Current Drug Targets. 2021, 22: 1. https://doi.org/10.2174/1389450122666210203193225

2. Jiang JZ#, Ma TY#, Zhang LH, Cheng XM, Wang CH*. The transdermal performance, pharmacokinetics and anti-inflammatory pharmacodynamics evaluation of harmine-loaded ethosomes. Drug Development and Industrial Pharmacy. Drug Development and Industrial Pharmacy. 2020, 46(1): 101-108.

3. Chang Y#, Jiang JZ#, Chen W, Yang W, Chen LL, Qian SZ, Zhou T, Wu LF, Hong LH, Huang YZ*, Li F*. Biomimetic Metal-organic Nanoparticles Prepared with a 3D-printed Microfluidic Device as a Novel Formulation for Disulfiram-based Therapy against Breast Cancer. Applied Materials Today, 2020, 18: 100492.

4. Jiang JZ, Yang BH, Ji LL, Yang L, Mao YC, Hu ZH, Wang ZT, Wang CH*. Metabolic-induced cytotoxicity of diosbulbin B in CYP3A4-expressing cells, Toxicology in Vitro, 2017, 38(2): 59-66.

5. Zhen ZN, Zhang JX, Jiang JZ, He Y, Zhang WY, Mo XP, Kang XJ, Xu Q*, Wang B, Huang YZ*. Remodeling Tumor Immune Microenvironment (TIME) for Glioma Therapy Using Multi-Targeting Liposomal Codelivery. Journal for ImmunoTherapy of Cancer, 2020, 8(2): e000207.

6. Yang LJ, Jiang JZ, Hong JY, Di J, Liao YH, Kuang HX, Wang XT*. High drug payload 10-Hydroxycamptothecin nanosuspensions stabilized by cholesterol-PEG: in vitro and in vivo investigation, Journal of Biomedical Nanotechnology, 2015, 11(4): 711-721.




上一条:刘天琪

下一条:陈雪瑞